Brenton Taylor sold $26k of SGHT
EVP, Operations & R&D at Sight Sciences, Inc.. 2,988 shares at an average of $8.85, traded Oct 2, 2026, filed Oct 5, 2026.
Score components
- +15RoleOfficer
- +5Trade size$26k at market
- 0Share of holdings soldSold 1.1% of holdings
- +15Cluster5 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-414283, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | SOpen-market sale Common Stock10b5-1 | -2,988 | $8.85 | $26k | 261,990 | 7 d ago |
Related signals
Other insiders at Sight Sciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 18Weak | Sight Sciences, Inc. | David Badawi Chief Technology Officer | $71k 7,797 shares | -0% | |
| 33Weak | Sight Sciences, Inc. | Paul Badawi President and CEO | $268k 29,653 shares | -0% | |
| 27Weak | Sight Sciences, Inc. | Alison Bauerlein Chief Operating Officer | $224k 25,260 shares | -4% | |
| 25Weak | Sight Sciences, Inc. | James Rodberg Chief Financial Officer | $64k 7,208 shares | -3% | |
| 15Weak | Sight Sciences, Inc. | David Badawi Chief Technology Officer | $32k 4,836 shares | -0% | |
| 31Weak | Sight Sciences, Inc. | Paul Badawi President and CEO | $148k 22,362 shares | -0% | |
| 38Weak | Sight Sciences, Inc. | David Badawi Chief Technology Officer | $73k 9,660 shares | -1% | |
| 54Moderate | Sight Sciences, Inc. | Paul Badawi President and CEO | $277k 37,226 shares | -1% | |
| 46Moderate | Sight Sciences, Inc. | Alison Bauerlein Chief Operating Officer | $157k 20,543 shares | -3% | |
| 25Weak | SGHTbuy Sight Sciences, Inc. | Staffan Encrantz director, owner | $116k 13,958 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.